Disease X : Beyond Fear, Toward Preparedness
Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net..
In recent years, there has been a growing concern regarding the increasing incidence of infectious diseases with potential global transmission [1]. The World Health Organization (WHO) coined the phrase "Disease X" to denote a theoretical infectious disease that has not yet been detected but has the capacity to cause a global pandemic. Disease X denotes an unidentified pathogenic agent with the potential to instigate a forthcoming global outbreak [2]. Commencing with a convened gathering on the 18th of November 2022, the WHO has initiated a comprehensive assembly of more than 300 esteemed experts. The primary objective of this assembly is to meticulously examine the available information pertaining to over 25 virus families, bacteria, and a hypothetical pathogen referred to as "Disease X." The initial publication of the list occurred in 2017.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - year:2024 |
|---|---|
| Enthalten in: |
Infectious disorders drug targets - (2024) vom: 23. Jan. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Awasthi, Rajendra [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Revised 24.01.2024 published: Print-Electronic Citation Status Publisher |
|---|
| doi: |
10.2174/0118715265285021240104091449 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367557983 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367557983 | ||
| 003 | DE-627 | ||
| 005 | 20240124232256.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240124s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.2174/0118715265285021240104091449 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1269.xml |
| 035 | |a (DE-627)NLM367557983 | ||
| 035 | |a (NLM)38265375 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Awasthi, Rajendra |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Disease X |b Beyond Fear, Toward Preparedness |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 24.01.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status Publisher | ||
| 520 | |a Copyright© Bentham Science Publishers; For any queries, please email at epubbenthamscience.net. | ||
| 520 | |a In recent years, there has been a growing concern regarding the increasing incidence of infectious diseases with potential global transmission [1]. The World Health Organization (WHO) coined the phrase "Disease X" to denote a theoretical infectious disease that has not yet been detected but has the capacity to cause a global pandemic. Disease X denotes an unidentified pathogenic agent with the potential to instigate a forthcoming global outbreak [2]. Commencing with a convened gathering on the 18th of November 2022, the WHO has initiated a comprehensive assembly of more than 300 esteemed experts. The primary objective of this assembly is to meticulously examine the available information pertaining to over 25 virus families, bacteria, and a hypothetical pathogen referred to as "Disease X." The initial publication of the list occurred in 2017 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a Disease X | |
| 650 | 4 | |a Ebola virus disease | |
| 650 | 4 | |a Middle East respiratory syndrome | |
| 650 | 4 | |a Nipah diseases | |
| 650 | 4 | |a World Health Organization | |
| 650 | 4 | |a Zika virus | |
| 773 | 0 | 8 | |i Enthalten in |t Infectious disorders drug targets |d 2006 |g (2024) vom: 23. Jan. |w (DE-627)NLM163628408 |x 2212-3989 |7 nnns |
| 773 | 1 | 8 | |g year:2024 |g day:23 |g month:01 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.2174/0118715265285021240104091449 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |j 2024 |b 23 |c 01 | ||